A Message From Dr. Charles B. Hensley

As a young man, I was fortunate to achieve great success with the very first product I developed. That product was Zicam. At the time, I thought it was all about the money and accolades. While I knew that I had developed something special, I didn't realize the true significance of the product itself.

That realization came to me when a mother of an eight year old daughter called me one afternoon and told me her daughter had only one lung, suffered greatly from colds and that the colds always led to secondary bacterial infections. Doctors warned that her daughter would ultimately lose the function in her one remaining lung because of the cold infections.

The mom told me that she began religiously administering Zicam to her daughter whenever she started to see any sign of a sniffle and that her daughter had not had a cold in the past two years. As this Mom, crying on the phone, thanked me for saving her little girls life, I realized for the first time what was truly important. Although I had endured years of economic hardship while developing Zicam and preparing it for market, it was absolutely worth it. What a blessing!

In 2010, a friend whose business associate suffered greatly from migraine headaches asked me if I could help his friend. I respectfully declined only to have my friend call me again asking if I could help. Again, I declined. Finally, after several more pleas for help from my friend I agreed to meet with Mr. Farley

When I met Mr. Farley, I was taken back by his demeanor. He was tired, depressed and very frustrated. It seemed the medical establishment had really let him down. He told me that he suffered severe migraine headaches each and every day for the past twenty years. His typical day would start with the beginnings of a migraine headache and by 10 am, he would have unbearable pain. He would take up to three Imitrex a day and even then there was no relief for him.

After meeting Mr. Farley and hearing his story, I decided to look into the migraine headache scientific literature. To say I was surprised at the lack of attention and research funding devoted to this affliction would be a gross understatement. I found it nothing short of appalling that this situation could exist leaving over 36 million people in the United States and 1 billion people worldwide suffering.

Over the next several months, I explored every aspect of migraine and tried to understand its cause. What was readily apparent from the very beginning, was that the widely accepted theories of the cause of migraine headache were flawed. To me, this meant that the approach and therapeutic targets that the drug companies were taking were off the mark. It was a classic case of old theories and dogmatic thinking leading everyone in the wrong direction.

Driven by a strong desire to help Mr. Farley and all migraine sufferers, I developed a theory of the cause of migraines and based on this theory, I developed Migranade Migraine Relief. Soon after, the open label study confirmed what we already knew; Migranade Migraine Relief truly represents a revolutionary breakthrough in the way migraine headaches are treated.

I am blessed to be part of a solution to this problem that not only impacts the sufferers, but their spouses, children and all of those who love and care about them.

As we embark on our quest to provide much needed relief to millions upon millions of migraine sufferers I hope you will join our Migranade Migraine Relief family. I appreciate you taking the time to read this message, thank you.


Charles B. Hensley, Ph.D.
Chairman and CEO
Migranade, Inc.